Skip to content
Live
Market Cap:$2.32T+1.17%
24h Vol:$71.4B
BTC:56.5%
ETH:10%
Coins:17,674
Updated 11:15 AM
Injective

Injective

INJ
NA Capital-as-a-Service SSTN
NA Capital-as-a-Service SSTN
PC0016245

Fundamental comparison between Injective and NA Capital-as-a-Service SSTN

Not Financial Advice

This page is an informational analysis, not investment advice. The CryptoValue Score is an algorithmically generated rating from public data — it does not replace professional advice. Cryptocurrencies are highly volatile; total loss is possible. Read full risk disclaimer →

Injective

Injective

71
050100
Undervalued
24h+4.00%
7d-9.10%
NA Capital-as-a-Service SSTN

NA Capital-as-a-Service SSTN

42
050100
Fair Value
24h+0.00%
7d+0.00%

Detailed Comparison

MetricInjectiveNA Capital-as-a-Service SSTN
Price$4.90$1.00
Market Cap$489.86M$25.00M
24h Volume61.8M0
Rank#—#—
Circulating Supply100M25M
ATH$52.62$1.00

Injective vs NA Capital-as-a-Service SSTN — Analysis

Injective and NA Capital-as-a-Service SSTN are two of the most prominent cryptocurrencies in the market. This comparison analyzes both coins based on their current price, market capitalization, trading volume, and — most importantly — their CryptoValue Value Score, which is calculated from 10 fundamental on-chain and market metrics.

Value Score Comparison

With a Value Score of 70.7, Injective is currently rated as "undervalued", while NA Capital-as-a-Service SSTN scores 42.4 and is rated "fair value". This means our algorithm considers Injective the fundamentally stronger investment — with a significant gap of 28.300000000000004 points.

Injective has the higher Value Score (70.7/100)

Market Cap & Risk

Injective has a 20x larger market capitalization than NA Capital-as-a-Service SSTN. A larger market cap typically means less volatility but also less growth potential. NA Capital-as-a-Service SSTN may offer more upside but comes with higher risk.

Price Performance

Over the last 24 hours, Injective moved 4.00%, while NA Capital-as-a-Service SSTN changed 0.00%. Looking at the 7-day window, Injective is at -9.10% and NA Capital-as-a-Service SSTN at 0.00%.

Distance from All-Time High

Injective currently trades at 9% of its all-time high ($52.62), while NA Capital-as-a-Service SSTN sits at 100% of its ATH ($1.00). Coins trading far below their ATH can represent either a buying opportunity or a warning sign — the Value Score helps distinguish between the two.

Conclusion

Based on our fundamental analysis, Injective (Score: 70.7) currently has a stronger investment case than NA Capital-as-a-Service SSTN (Score: 42.4). However, the Value Score is a snapshot that changes daily. We recommend monitoring both coins regularly and conducting your own research before making any investment decisions.

Trezor Safe 5 — Secure your crypto